临床原料药生产

Reliable manufacturing of drug substances for clinical trials is critical for any pharmaceutical company, but it can be particularly challenging for small and emerging organizations if they lack the in-house 专业知识, 在后期阶段需求变大时所需的容量或规模.

在国家授权正规彩票平台, our flexible clinical manufacturing services can supply the clinical trial drug substance materials you need to meet your changing demands. We work closely with your team to understand the clinical development plan and to provide a nimble and flexible clinical manufacturing solution. Our highly trained operations team collaborates closely with our process chemists and process engineers, who accompany the process into the pilot manufacturing facility to ensure smooth transfer to later-phase clinical batches through commercial launch.

We operate multiple manufacturing facilities to meet the varying demands of clinical trials, with the capabilities to produce active pharmaceutical ingredients (APIs) for Phase I through large Phase III trials and beyond:

爱沙尼亚塔林
支持非gmp合成的原料药和中间体高达10公斤.

达勒姆，北卡罗来纳州，美国
支援第一至第二阶段，容量由1公升至200公升.

沃尔瑟姆，马萨诸塞州，美国 (金鱼草化学)
支援第一期至第二期工程，容量由1公升至100公升.

朗蒙特，CO, USA
支持第一阶段至第二阶段，容量从5升到200升.

美国北卡罗来纳州的高点
支持第一阶段的商业投放，容量从5升到2000升.

查尔斯市，IA，美国
Support for late Phase II through commercial launch with capacity from 400 L to 16,000 L.

Karlskoga、瑞典
Support for late Phase II through commercial launch with capacity from 50 L to 12,000 L.

保罗(米兰)，意大利
Support for late Phase II through commercial launch with capacity from from 37 L to 14,000 L.

Our experts and facilities are equipped to handle your unique clinical trial demands. 通过选择国家授权正规彩票平台作为即将到来的试验的临床生产合作伙伴, you can be confident that you will receive high-quality API and exceptional support at every step.